Vertex Pharmaceuticals Inc (NAS:VRTX)
$ 422.78 3.79 (0.9%) Market Cap: 109.10 Bil Enterprise Value: 99.65 Bil PE Ratio: 27.44 PB Ratio: 5.89 GF Score: 94/100

Vertex Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 02:10PM GMT
Release Date Price: $234.64 (-1.00%)
Cory William Kasimov
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst

All right. Good morning, and once again, welcome to the 39th annual and first, and hopefully, only time, Virtual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm a senior large-cap biotech analyst, and it's my pleasure to introduce our next company, Vertex. And CEO, Reshma Kewalramani.

Please note that this -- after the presentation, we will have a Q&A session right here in the same Zoom room. (Operator Instructions) And if it's easier, you can also e-mail me questions as well, and I'll be monitoring my inbox.

So with that, let me turn things over to you, Reshma.

Reshma Kewalramani
Vertex Pharmaceuticals Incorporated - CEO, President & Director

All right. Great. Thanks so much, Cory. Good morning all. Despite the very different format and the inability to see any of you, I'm really pleased to be here today and excited to share a preview of where we're headed in 2021 and beyond.

We're poised to deliver continued

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot